CONMED CORPORATION Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax
CONMED CORPORATION (CNMD) reported Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax of -$3.42 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax · last filed 2026-02-17
- CONMED CORPORATION other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, before tax for fiscal 2025 was -$3.42M.
- CONMED CORPORATION other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, before tax for fiscal 2024 was -$2.49M.
- CONMED CORPORATION other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, before tax for fiscal 2023 was -$6.58M.
- CONMED CORPORATION other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, before tax for fiscal 2022 was -$7.82M.
| Period end | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax 12 month |
|---|---|
| 2025-12-31 | -$3.42M 10-K · filed 2026-02-17 |
| 2024-12-31 | -$2.49M 10-K · filed 2026-02-17 |
| 2023-12-31 | -$6.58M 10-K · filed 2026-02-17 |
| 2022-12-31 | -$7.82M 10-K · filed 2025-02-18 |
| 2021-12-31 | -$9.16M 10-K · filed 2024-02-28 |
| 2020-12-31 | $6.50M 10-K · filed 2023-02-21 |
| 2019-12-31 | -$35.00K 10-K · filed 2022-02-22 |
| 2018-12-31 | $885.00K 10-K · filed 2021-02-22 |
| 2017-12-31 | -$1.02M 10-K · filed 2020-02-24 |
| 2016-12-31 | $755.00K 10-K · filed 2019-02-25 |
| 2015-12-31 | -$7.58M 10-K · filed 2018-02-26 |
| 2014-12-31 | $18.78M 10-K · filed 2017-02-27 |
| 2013-12-31 | -$18.18M 10-K · filed 2016-02-23 |
| 2012-12-31 | -$1.39M 10-K · filed 2015-02-23 |
| 2011-12-31 | $20.25M 10-K · filed 2014-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |